Frameworks for Digital Advertising
Standards in Medicine.

Poland · Advertising framework

Television advertising for medical devices in Poland

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Professional-use devices cannot be publicly advertised

Legal requirement — paraphrased

Applies when: The advertised offer is a regulated device or IVD.

For a regulated device/IVD, public advertising cannot concern a device intended for users other than laypersons. Public creative cannot use healthcare professionals, people posing as them, or presentations suggesting that profession; nor directly urge children to buy or persuade adults to buy.

Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Article 55

Keep device claims within the assessed intended purpose

Legal requirement — paraphrased

Applies when: The advertised offer is a regulated device or IVD.

If this is a device/IVD, do not invent functions, diagnostic performance or safety; imply unassessed uses; or obscure likely risks. Do not mislead about servicing or software updates. Explain claims in language a layperson can understand.

Sources: URPL — Advertising medical devices; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · MDR/IVDR Article 7 as explained by URPL; Device Act Articles 54–55

Obtain written approval and keep device-advertising records

Legal requirement — paraphrased

Applies when: The advertised offer is a regulated device or IVD.

For a regulated device/IVD, an advertiser other than the relevant economic operator needs that operator's written approval. Keep public-advertising specimens and placement information for two years after the end of the calendar year of dissemination; media providers/publishers have a separate minimum one-year retention duty.

Sources: URPL — Advertising medical devices · Device Act Articles 56 and 61, explained by URPL

Include device identity and the correct Polish warning

Legal requirement — paraphrased

Applies when: The exact message is public device advertising, including qualifying device-based service advertising under Article 58.

Apply this module only to qualifying public device advertising, including a device-based service falling within Article 58. It does not make an otherwise prohibited advertisement permissible.

For public device/IVD advertising, identify the advertiser, manufacturer and appointed authorised representative, alongside device name and intended purpose. The warning is: To jest wyrób medyczny. Używaj go zgodnie z instrukcją używania lub etykietą.

For Annex XVI non-medical-purpose products and device accessories, the regulation instead specifies: Dla bezpieczeństwa używaj zgodnie z instrukcją używania lub etykietą. Determine the correct branch before drafting.

Sources: Medical-device advertising regulation — Dz.U. 2023 item 817; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Sections 1–3

Fit device warnings to image, audio or video

Legal requirement — paraphrased

Applies when: The exact message is public device advertising, including qualifying device-based service advertising under Article 58.

Apply this module only to qualifying public device advertising, including a device-based service falling within Article 58. It does not make an otherwise prohibited advertisement permissible.

Audiovisual: warning in the bottom 15% or more, clearly spoken in Polish for at least four seconds. Audio: at least four seconds of clear Polish warning. Visual: bottom 10% or more, on the first page of multipage advertising. Observe the prescribed contrast, static horizontal text and spacing.

Sources: Medical-device advertising regulation — Dz.U. 2023 item 817; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Section 3(3)

Identify the operator responsible for advertising approval

Regulator guidance

Applies when: The offer is a regulated device or IVD.

Written approval for an outside advertiser does not transfer the economic operator’s statutory responsibility to the agency or creator. Keep approval and publication records attached to the exact version of the advertisement.

The economic operator’s two-year period runs from the end of the calendar year of dissemination. The separate media-provider/publisher minimum is one year; these are different duties.

Sources: URPL — Advertising medical devices · URPL overview: written approval, responsibility and retention; Act Articles 56 and 61

Channel rules

Make the overall message truthful and commercially identifiable

Legal requirement — paraphrased

Misleading claims, material omissions, hidden commercial intent and aggressive consumer marketing are prohibited. Assess visuals, comparisons, qualifications and the impression on vulnerable consumers. Do not falsely claim that a product cures illness.

Editorial control: retain substantiation before publication, remove fabricated urgency or authority badges, and check that qualifications do not contradict the headline. Paying to publish apparently independent advice must not conceal its commercial nature.

Sources: Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Articles 4–9; Article 7 hidden advertising and false cure claims

Check price reductions only after establishing that promotion is lawful

Legal requirement — paraphrased

Where an advertisement announces a reduction for a good or service, state the relevant lowest price from the preceding 30 days alongside the reduced price. For a shorter selling history, use the lowest price since sales began; special rules apply to rapidly perishable goods.

This consumer-information rule does not permit a discount or purchasing incentive prohibited by medicine or service rules. As an editorial check, make the total scope and extra charges clear.

Sources: UOKiK — Information about price reductions · Price Information Act Article 4 as explained by UOKiK

Keep reviews genuine and explain verification

Legal requirement — paraphrased

Do not publish, commission or distort false consumer recommendations. If making consumer reviews available, explain whether and how their origin is verified. Do not claim authentic-user verification without reasonable, proportionate checks.

Selecting a patient or customer story for advertising also requires checking the sector's claims and endorsement restrictions. A genuine testimonial can still contain an unlawful health claim.

Sources: UOKiK — False reviews? Stop!; Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Unfair-practices Act Articles 6–7; UOKiK reviews guidance

Broadcast advertising adds separation, sponsorship and placement rules

Legal requirement — paraphrased

Commercial communications must be recognisable; hidden or subliminal advertising is prohibited. Advertising of healthcare services available exclusively on a doctor's referral is prohibited in the broadcasting regime. Product and provider restrictions apply in addition.

Sponsorship and product placement have separate conditions and cannot be used to bypass prohibited advertising. Have the broadcaster classify the execution and check the applicable restrictions, rather than treating a sponsorship ident as a normal ad slot.

Sources: Broadcasting Act — consolidated text, Dz.U. 2022 item 1722 · Articles 16, 16b–16c, 17 and 17a

Approve the television master with its warning panel

Editorial recommendation

For an otherwise lawful medicine/device advertisement, verify the sector-specific audiovisual warning area, Polish reading, duration, contrast and spacing on the broadcast master. Review presenters, clinical-looking costumes, outcomes and child appeal before recording.

As an editorial control, approve every cut-down and aspect ratio separately. A late-added warning does not repair an ineligible product, prohibited presenter or misleading script.

Sources: Medicine advertising regulation — consolidated text, Dz.U. 2023 item 1648; Medical-device advertising regulation — Dz.U. 2023 item 817; Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Audiovisual formats and public-presentation restrictions

Campaign workflow

Keep one campaign evidence and approval record

Editorial recommendation

Recommended workflow: record the exact offer and legal classification, advertiser, selected channel and creative formats; list permitted claims and evidence; review the Polish execution and destination; record sign-off, publication and corrections.

Keep the source date with the rule. Recheck legislation flagged as changing, especially pharmacy advertising. Preserve statutory archive periods where they apply; this suggested general workflow does not create a universal retention period.

Sources: URPL — Advertising medical devices; Sejm official API — Pharmacy advertising amendment, process 3002 · Specific retention and legislative-watch sources; workflow is editorial

Pre-publication checklist

  • Record the category gate before reviewing the channel.
  • Approve the final creative, disclosure, targeting and landing page together.
  • Assign an owner for corrections, expiry of claims and legislative updates.

Scope and unresolved questions

  • Product authorisations, intended users, approved documentation and final Polish creative must be checked for the actual offer. Veterinary products, controlled substances, vaccine exceptions and specialist product subtypes are not separately cleared by this category-level guide.
  • Confirm the service's legal classification, broadcaster jurisdiction and booking format. Cross-border broadcasts, on-demand services, sponsorship and product placement can need additional analysis.
Research scope, introduction and dates

Before promoting medical devices in television campaigns in Poland, identify the intended user and the device's assessed purpose. The distinction between lay-use and professional-use products shapes the public-advertising review, alongside presentation and warning requirements.

For television, assess both the creative and the broadcaster's classification of the placement. Presenter choice, voiceover, warning panels and cut-down versions need to work within the same execution; sponsorship and product placement have their own conditions.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: Source-checked editorial research for all listed categories; campaign-specific legal review pending.

Resolve product and service restrictions before choosing a channel

Editorial overview

A platform label, newsletter consent, an advertising warning or a publisher's acceptance does not create permission to advertise. Apply the selected product/service gate first; if public promotion is prohibited, use this guide to identify the restriction and alternatives for specialist review.

This English guide describes Polish requirements. Required Polish warning text and locally understandable disclosure remain necessary where the law requires them.

Sources: Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612; Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Product/service rules referenced in matching modules

Confirm whether the offer is a medical device or IVD

Editorial overview

For diagnostics and digital health, first establish whether this is a regulated device, an IVD, a healthcare service or a general wellness product. The following device rules apply only where the advertised product qualifies as a device/IVD. A CE mark is not regulatory approval of advertising claims.

Sources: Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620; URPL — Advertising medical devices; MDCG 2019-11 rev.1 — Software qualification and classification, June 2025 · Device Act Articles 54–56; MDCG section 3

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620

    Polish Parliament · legislation · checked 2026-10-24

    The inspected PDF is dated 19 November 2024. Advertising provisions were cross-checked against the current URPL advertising overview; recheck amendments before campaign sign-off.

  2. Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612

    Polish Parliament · legislation · checked 2026-10-24

    Consolidation reflects 8 April 2026. Later amendments exist; pharmacy advertising must also be read with the CJEU judgment and the October 2026 legislative tracker in the pharmacy framework. This is a targeted advertising review, not an audit of the entire Act.

  3. Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156

    Polish Parliament · legislation · checked 2026-10-24

    Public information must not have advertising characteristics. Information supplied at a patient's request under paragraph 2 is a different context.

  4. URPL — Advertising medical devices

    URPL, Poland · regulator guidance · checked 2026-10-24

  5. MDCG 2019-11 rev.1 — Software qualification and classification, June 2025

    Medical Device Coordination Group; hosted by European Commission · regulator guidance · checked 2026-10-24

    Non-binding MDCG guidance; the document expressly is not the Commission's official position.

  6. Medical-device advertising regulation — Dz.U. 2023 item 817

    Minister of Health, Poland · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  7. Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845

    Polish Parliament · legislation · checked 2026-10-24

  8. UOKiK — Information about price reductions

    Office of Competition and Consumer Protection, Poland · regulator guidance · checked 2026-10-24

  9. UOKiK — False reviews? Stop!

    Office of Competition and Consumer Protection, Poland · regulator guidance · checked 2026-10-24

    The 30 July 2024 announcement also describes enforcement decisions; their subsequent appeal status is not asserted here.

  10. Broadcasting Act — consolidated text, Dz.U. 2022 item 1722

    Polish Parliament · legislation · checked 2026-10-24

    Later amendments exist. The cited advertising provisions were inspected; do not infer that an ordinary social account is automatically an on-demand audiovisual media service.

  11. Medicine advertising regulation — consolidated text, Dz.U. 2023 item 1648

    Minister of Health, Poland · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  12. Sejm official API — Pharmacy advertising amendment, process 3002

    Polish Parliament · legislative tracker · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

From framework to action

Local expertise in Poland

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Poland.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

Marketing & sales advisory

Casbeg

Marketing and sales consulting for businesses in Poland: strategy, commercial processes, lead generation and CRM implementation.

View partner profile

Business & project coordination

No partners listed in this category yet.

Browse partners in Poland

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.